IIT-H collaborates with PharmCADD for co-development of new drugs
HYDERABAD: The Indian Institute of Technology, Hyderabad (IIT-H) on Friday signed a memorandum of understanding (MoU) with PharmCADD, an in-silico drug design company, for co-development of new drugs.
Last month, PharmCADD founded a local corporation in India and is intensively hiring competent Indian researchers. The IIT-H and PharmCADD also agreed to promote collaboration by jointly participating in global research and development projects.
Under this MoU, IIT-H will provide PharmCADD with key members to conduct academic research in the field of artificial intelligence, molecular dynamic simulation and quantum calculation for new drug development. “IITH has dedicated faculty working on many novel techniques and drugs. This global collaboration in the field of drug development will definitely strengthen our capabilities to develop novel formulations and make a healthier society,” said Prof BS Murty, director, IIT-H.
Last month, PharmCADD founded a local corporation in India and is intensively hiring competent Indian researchers. The IIT-H and PharmCADD also agreed to promote collaboration by jointly participating in global research and development projects.
“PharmCADD has designed and optimized the mRNA sequence for developing Covid-19 mRNA vaccine and the mRNA vaccine candidate has been recently applied for investigational new drug to begin clinical trial 1/2a study in Korea. Based on this experience, we have expanded a vaccine developing platform and enhanced the platform technology with the aid of IIT’s resources,” said Taehyung Kwon, chief executive officer, PharmCADD.
Under this MoU, IIT-H will provide PharmCADD with key members to conduct academic research in the field of artificial intelligence, molecular dynamic simulation and quantum calculation for new drug development. “IITH has dedicated faculty working on many novel techniques and drugs. This global collaboration in the field of drug development will definitely strengthen our capabilities to develop novel formulations and make a healthier society,” said Prof BS Murty, director, IIT-H.
All Comments ()+^ Back to Top
Refrain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks, name calling or inciting hatred against any community. Help us delete comments that do not follow these guidelines by marking them offensive. Let's work together to keep the conversation civil.
HIDE